Andrew Gifford — ASN Events
  1. Schedule
  2. Andrew Gifford

Andrew Gifford

Children's Cancer Institute, NSW, Australia

  • This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:

CBL0137, a novel NFkB suppressor and p53 activator, is highly effective in two independent pre-clinical mouse models of neuroblastoma (#136)

2:15 PM
Jayne Murray
Afternoon Tea/Poster Session